A study on Seenakara Parpam in the management of Kalladaippu (Renal Calculi)

An open non randomized single arm single centric clinical trial to evaluate the effectiveness of Seenakara Parpam for the management of Kalladaippu (Renal Calculi) among out-patients attending Ayothidoss Pandithar Hospital, National Institute of Siddha - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069261

Enrollment

Registered

2024-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney

Interventions

Intervention1: Seenakara Parpam: Panavedai alavu(488 mg)Twice a day(after food) for 45 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients without any of the classical symptoms but having the stone size greater than or equal to 4mm to lesser than or equal to 10 mm 2.Patient willing to sign the informed consent 3.Patient who are willing to take Ultrasonography investigation (USG - Abdomen/KUB) and provide blood sample for lab investigation

Exclusion criteria

Exclusion criteria: 1.Stone size greater than 10mm and lesser than 4mm 2.Pregnant women 3.Lactating mother 4.Thyroid dysfunction 5.Chronic kidney disease 6.Obstructive uropathy 7.Pyelonephritis 8.Pyonephritis 9.Hydronephrosis

Design outcomes

Primary

Measure	Time frame
The therapeutic effectiveness of siddha formulation Seenakara Parpam in the management of kalladaippu (renal calculi) for the clearance / reduction in the size of renal calculi will be determined in USG Abdomen /KUBTimepoint: 12 months	—

Secondary

Measure	Time frame
Proportion of patients achieving minimally clinically important difference of stone size reductionTimepoint: 12 months	—

Countries

India

Contacts

Public ContactDr H Vetha Merlin Kumari

National Institute of Siddha

dr.vetha@gmail.com9894782366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026